Paul Lammers
Direttore/Membro del Consiglio presso SALARIUS PHARMACEUTICALS, INC.
Patrimonio netto: 857 $ in data 30/04/2024
Posizioni attive di Paul Lammers
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SALARIUS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 19/07/2019 | - |
| Independent Dir/Board Member | 19/07/2019 | - | |
ImmunoMet Therapeutics, Inc.
 ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Direttore/Membro del Consiglio | 28/11/2017 | - |
Triumvira Immunologics, Inc.
 Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada. | Direttore/Membro del Consiglio | 01/01/2018 | - |
| Amministratore Delegato | 01/01/2018 | - | |
| Presidente | 01/01/2018 | - | |
Triumvira Immunologics USA, Inc.
 Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Direttore/Membro del Consiglio | 01/01/2018 | - |
| Amministratore Delegato | 01/01/2018 | - | |
| Presidente | 01/01/2018 | 24/10/2022 |
Storia della carriera di Paul Lammers
Precedenti posizioni note di Paul Lammers
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Mirna Therapeutics, Inc.
 Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Direttore/Membro del Consiglio | 01/11/2009 | 01/08/2017 |
| Amministratore Delegato | 01/11/2009 | 01/08/2017 | |
| Presidente | 01/11/2009 | 01/08/2017 | |
| REPROS THERAPEUTICS INC | Presidente | 23/02/2009 | 28/10/2009 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Direttore Tecnico/Scientifico/R&S | 01/07/2002 | 01/09/2008 |
Formazione di Paul Lammers
| Radboud University Nijmegen | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Paesi Bassi | 2 |
| Canada | 2 |
Posizioni
| Director/Board Member | 5 |
| President | 4 |
| Chief Executive Officer | 3 |
Settori
| Health Technology | 5 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 7 |
|---|---|
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Health Technology |
Triumvira Immunologics, Inc.
Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada. | Health Technology |
| Salarius Pharmaceuticals, Inc. | |
Triumvira Immunologics USA, Inc.
Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Commercial Services |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Commercial Services |
- Borsa valori
- Insiders
- Paul Lammers
- Esperienza
